Balance of Nature ordered to stop selling supplements - cspi.org
Balance of Nature ordered to stop selling supplements by FDA/CSPI action.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on July 29, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Critical. Balance of Nature and potentially other dietary supplement manufacturers facing similar FDA enforcement. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate (order effective upon issuance).. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA ordered Balance of Nature to cease selling its supplements, likely due to cGMP violations or unapproved drug claims.
Who it affects
Balance of Nature and potentially other dietary supplement manufacturers facing similar FDA enforcement.
What you must do
Immediately halt sales and distribution of affected supplements; review compliance with cGMP and labeling regulations.
Deadline
Immediate (order effective upon issuance).
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- FDA Proposes Rule to Modernize Drug Manufacturing Registration - mymalonetelegram.com
- Texas outsourcer in Lilly's compounded tirzepatide lawsuit hit with FDA warning letter - fiercepharma.com
- CONCORD – An Arizona company and CEO pleaded guilty today in federal - fda.gov
- August 29, 2022: FDA warns “Tramadol US” to stop selling controlled, unapproved drugs to U.S. residents - safemedicines.org
- Outsourcing Facility Fee Rates for Fiscal Year 2027